REVIEW   

Minerva Endocrinology 2022 March;47(1):117-26

DOI: 10.23736/S2724-6507.21.03523-5

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

COVID-19 and endocrine and metabolic disorders: critical points and suggestions for a correct therapeutic management from a tertiary endocrine center in Italy

Marianna MARTINO, Gianmaria SALVIO, Melissa CUTINI, Giorgio ARNALDI, Giancarlo BALERCIA✉

Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy

The Coronavirus-19 (COVID-19) pandemic, which began in December 2019 in Wuhan, China, has spread rapidly worldwide, affecting mostly frail individuals and resulting in high lethality among people with chronic conditions. The management of chronic endocrine disorders during the pandemic period proved particularly challenging, as they require close physician-patient contact for proper long-term management. In addition, acute endocrinologic conditions that presented during the COVID-19 period required timely management in an unusual clinical setting, providing an ongoing challenge for clinicians. This article summarizes the most recent guidance on the management and therapy of frequent conditions such as diabetes and osteoporosis and less common endocrine disorders (e.g., adrenal insufficiency) in this setting.

KEY WORDS: COVID-19; SARS-CoV-2; Endocrine system diseases